Surgical adhesion barriers areimplants or solutions used to prevent internal scarring due to sticking oftissues or internal organs to each other after surgery or during healingprocess. Majority of adhesion barrier products are in nascent stage of productlife cycle and thus market is evolving gradually. Adhesion barrier productsconsidered in the report include film-based, solution-based, and gel-basedadhesion barriers.
The global SurgicalHemostats, Internal Tissue Sealants and Adhesion Barriers Market isestimated to account for US$ 4,231.4 Mn in terms of value in 2020 and isexpected to reach US$ 7,346.7 Mn by the end of 2027
Global Surgical Hemostats,Internal Tissue Sealants and Adhesion Barriers Market: Drivers
High number of cardiovascularprocedures is expected to propel growth of the global surgical hemostats,internal tissue sealants and adhesion barriers market over the forecast period.For instance, according to American Heart Association 2019 Heart Disease andStroke Statistics, 1,016,000 cardiac catheterizations and 3,244 hearttransplants were performed in the U.S. in 2014 and 2017, respectively.
Global Surgical Hemostats,Internal Tissue Sealants and Adhesion Barriers Market: Opportunities
R&D of absorbable hemostatsis expected to offer lucrative growth opportunities for players in the market.For instance, in October 2019, researchers from Institute of Pharmacology andToxicology, Technische Universität Dresden, Germany, reported that naturallyprefabricated marine biomaterials can aid in development of new spongechitin-based absorbable hemostats as alternatives to cellulose-based fabrics.
Global Surgical Hemostats,Internal Tissue Sealants and Adhesion Barriers Market: Restraints
Restricted use of synthetictissue sealants is expected to hinder growth of the market. Significantrestrictions and complications are associated with the use of syntheticpolymer-based tissue glues in the internal applications. For instance,cyanoacrylate glues have adequate acceptability for most orthopedic surgicalprocedures, however, are not yet cleared for use in the internal tissueapplications because of toxic effects. They additionally need sufficientadaptability for use in numerous procedures.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/3721
Key Takeaways:
Hemostat held dominant positionin the global surgical hemostats, internal tissue sealants and adhesionbarriers market in 2019, accounting for 41.1% share in terms of value, followedby Internal Tissue Sealants, and adhesion barriers respectively. Rising volumesof surgical procedures performed across the world coupled with increasingnumber of trauma and accident injury cases is expected to foster growth ofhemostats segment. For instance, according to the Health and Social CareInformation Centre (HSCIC), surgery is one of the most important treatmentsoffered by NHS care in the U.K., and accounted for 4.7 million admissionsacross multiple medical domains in 2013 -14.
Orthopedic Surgeries segment helddominant position in the global surgical hemostats, internal tissue sealantsand adhesion barriers market in 2019, accounting for 27.5% share in terms ofvalue, followed by Cardiovascular Surgeries and Neurological Surgeries,respectively. Highest prevalence of bone related disorders has been reported inNorth America. For instance, according to the statistics by WHO, in U.S., bythe year 2040, around 78.4 million adults aged 18 years and older will havedoctor-diagnosed arthritis, compared to 54.4 million adults in 2013-2015
Hospitals segment held dominantposition in the global surgical hemostats, internal tissue sealants andadhesion barriers market in 2019, accounting for 67.1% share in terms of value,followed by ASCs and specialty clinics, respectively
Market Trends
Major players in the market arefocused on launching new products to expand their product portfolio. Forinstance, in June 2019, Ethicon, part of the Johnson & Johnson MedicalDevices Companies, received a 510(k) clearance from the FDA for its Vistasealapplicators, which spray a biological sealant to stem moderate bleeding duringopen or laparoscopic surgical procedures.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/surgical-hemostats-internal-tissue-sealants-and-adhesion-barriers-market-3721
Major players in the market arealso focussed on adopting M&A strategies to expand their product portfolio.For instance, in March 2018, Baxter International Inc. completed acquisition oftwo hemostat and sealant products from Mallinckrodt plc. RECOTHROM Thrombintopical (Recombinant) is the first and only stand-alone recombinant thrombinand PREVELEAK Surgical Sealant is used in vascular reconstruction.
Global Surgical Hemostats,Internal Tissue Sealants and Adhesion Barriers Market: Competitive Landscape
Major players operating in theglobal surgical hemostats, internal tissue sealants and adhesion barriersmarket include, Ethicon (Johnson & Johnson), Baxter International Inc.,Integra LifeSciences Holdings Corporation, Pfizer Inc., Tissuemed Ltd., Sanofi,Braun Melsungen AG, C.R. Bard, Inc., CryoLife, Inc., Cohera Medical, Inc., andCSL Behring.
Global Surgical Hemostats,Internal Tissue Sealants and Adhesion Barriers Market: Key Developments
December 2019: Ethicon, part ofthe Johnson & Johnson Medical Devices Companies, launched VISTASEAL FibrinSealant (Human) to help surgeons manage bleeding during surgery
December 2018: BaxterInternational Inc. launched its disposable curved applicator that is designedto enhance the delivery of its Floseal Hemostatic Matrix product line
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/3721
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
